	Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis. JAMA Oncol Zaorsky NG, Sun Y, Nabid A, Zapatero A, Bolla M, Joseph D, Maingon P, Guerrero A, Gonzalez AA, San-Segundo CG, Cabeza Rodríguez MÁ, Sole JM, Olivé AP, Steigler A, Souhami L, Carrier N, Armstrong JG, Gillham C, Pisansky TM, Schipper M, Sandler HM, Efstathiou JA, Lawton C, de Reijke TM, Attard G, Roy S, Morgan SC, Malone S, Hall WA, Nguyen PL, Shoag JE, Vince RA Jr, Calaway A, Garcia JA, Barata PC, Mendiratta P, Brown JR, Valle L, Rettig M, Dess RT, Jackson WC, Martin T, Jia AY, Steinberg M, Romero T, Kishan AU, Spratt DE. PMID: 41264309 [PubMed - as supplied by publisher]
	Research progress on the role of AGC kinase family in bladder cancer. Discov Oncol Su P, Yang Y, Luo X, Zhang N, Zheng H. PMID: 41264154 [PubMed - as supplied by publisher]
	The intricate interplay between circadian rhythm, androgen signaling, hormone therapy, and cellular senescence in prostate cancer. Cancer Metastasis Rev Heidari Horestani M, Baniahmad A. PMID: 41264145 [PubMed - indexed for MEDLINE]
	Outcomes of robot-assisted partial nephrectomy (RAPN) for cystic renal tumor. J Robot Surg Kobayashi K, Ito H, Numata Y, Honda S, Jikuya R, Tatenuma T, Noguchi G, Ueno D, Komeya M, Ito Y, Muraoka K, Hasumi H, Makiyama K. PMID: 41264063 [PubMed - indexed for MEDLINE]
	Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy. World J Urol Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Lijnen RAG, Mertens LS, Bussani R, Burger M, van Leenders GJLH, Boormans JL, Wullich B, Hartmann A, Pavan N, Pouessel D, van der Kwast TH, Allory Y, Zuiverloon TCM, Lotan Y, van Rhijn BWG, Mayr R. PMID: 41264026 [PubMed - in process]
	Predicting surgical outcomes in single-port robot-assisted partial nephrectomy: external validation and comparative analysis of PADUA, RENAL, and SPARE scores. World J Urol Carletti F, Valenzi FM, Tamborino F, Turcan A, Santarelli V, Biasatti A, Morgantini LA, Haberal HB, Vourganti S, Dal Moro F, Autorino R, Crivellaro S. PMID: 41264016 [PubMed - indexed for MEDLINE]
	Accelerating Drug Development in Hormone-NaÃ¯ve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res McHugh D, Dallos M, Teo MY, McBride SM, Gopalan A, Arfe A, Gaffney CD, Amjed M, McCann PJ, Benoliel H, Autio KA, Goh AC, Derudder K, Ryan CJ, Szmulewitz RZ, Morgans AK, Bubley GJ, Gupta S, Klein EA, Nguyen PL, Kibel AS, Wagner AA, Kaplan ID, Eggener S, Einstein DJ, Acosta AM, Tendulkar R, VanderWeele DJ, Catalona W, Sachdev S, Liauw SL, Eastham JA, Taplin ME, Scher HI. PMID: 41263694 [PubMed - as supplied by publisher]
	The lung immune prognostic index as a predictive biomarker in urological malignancies undergoing immune checkpoint inhibitor therapy. Ann Med He Y, Yuan Y, Wei X, Li L, Luo P. PMID: 41263670 [PubMed - indexed for MEDLINE]
	Polygenic Risk Score as a Predictor of Bone Fracture or Osteoporosis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy. Cancer Med Liu YQ, Chang LW, Yang HW, Li JR, Chen YM, Hung SC, Chen IC. PMID: 41263445 [PubMed - indexed for MEDLINE]
	[Unusual bone marrow metastasis revealed by recurrent haematuria]. Ann Biol Clin (Paris) Gabsi H, Audenet F, Verkarre V, Gibault L, Rivet N, Darnige L. PMID: 41263429 [PubMed - indexed for MEDLINE]
	Prostate Cancer Screening Practices Among High-Risk Patients: A Retrospective Analysis. Am J Mens Health Ghosh AK, Sivasubramanian BP, Asif RH, Barker S, Dirisanala S, Robinson SS, Rynarzewska AI, Johnson A. PMID: 41263152 [PubMed - indexed for MEDLINE]
	From chronic inflammation to immune escape: mapping the tumor microenvironment evolution in renal cell carcinoma. Front Immunol Xu H, Tu B, Li H, Shan Y. PMID: 41262243 [PubMed - indexed for MEDLINE]
	A Systematic Review of Artificial Intelligence-Based Clinical Decision Support Systems in Prostate Cancer Management. Healthc Technol Lett Naderian S, Soleimanzadeh F, Nikniaz L, Sanaie S, Sadeghi-Ghyassi F, Samad-Soltani T. PMID: 41262209 [PubMed]
	Idiopathic isolated adrenocorticotropic hormone deficiency combined with testicular germ cell tumor: Case report. Medicine (Baltimore) Yang M, Lin S, Fu D, Wang Y, Lu S, Li M, Wang X. PMID: 41261694 [PubMed - indexed for MEDLINE]
	Does incidental prostate cancer after holmium laser enucleation of the prostate cause serious clinical problems?: Retrospective study. Medicine (Baltimore) Efendio, Özcan C, Tokatli Z. PMID: 41261687 [PubMed - indexed for MEDLINE]
	Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial. BJC Rep Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E. PMID: 41261199 [PubMed]
	Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and Reality. Eur Urol Focus Crupi E, Necchi A, Kamat AM. PMID: 41261008 [PubMed - as supplied by publisher]
	Clinical outcomes of retreatment or discontinuation after interruption of nivolumab plus ipilimumab due to immune-related adverse events in metastatic renal cell carcinoma patients: A retrospective multicenter study. Urol Oncol Sano Y, Inoue M, Washino S, Shirotake S, Takeshita H, Miura Y, Nakayama A, Nagamoto S, Miyagawa T, Oyama M, Kawakami S, Saito K, Matsuoka Y. PMID: 41260972 [PubMed - as supplied by publisher]
	Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path Forward. Eur Urol Oncol Cerrato C, Rouprêt M, Mir MC. PMID: 41260941 [PubMed - as supplied by publisher]
	Corrigendum to "Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study" [Eur J Cancer 213 (December) (2024) 115078]. Eur J Cancer Azad AA, Fizazi K, Matsubara N, Saad F, De Giorgi U, Joung JY, Fong PCC, Jones RJ, Zschäbitz S, Oldenburg J, Shore ND, Dunshee C, Carles J, Fay AP, Lin X, DeAnnuntis L, Di Santo N, Zielinski MA, Agarwal N. PMID: 41259940 [PubMed - as supplied by publisher]

Articles 1 - 20 / 287616

Page 1 of 14381



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy